While the association between IGFBP-3 and sleep-related breathing disorders (SRBDs) in PWS remains unexplored, our study indicates that the heightened levels of IGF-1 and IGFBP-3 resulting from rhGH treatment do not adversely affect SRBDs. Here, IGF1 is linked to sleep apnea syndrome.